1966: Undergraduate Harvard College BA
1970: Medical Yale School of Medicine MD
1970-1971: Internship - University California, San Francisco Internal Medicine
1971-1972; Residency - University of California, San Francisco Internal Medicine
1972-1975: Fellowship - Harvard Medical School, Beth Israel Hospital Nephrology
Endothelial dysfunction in diabetes and renal disease
Mechanisms of renal ischemia
Acute kidney injury
Prevention of contrast induced nephropathy (CIN)
Regulation of electrolyte homeostasis in marine species
Educational initiative for patients with early renal insufficiency (PEAK program)
Pharmacology of antihypertensive drugs
Prevention and treatment of ischemic acute renal failure, including contrast nephropathy
Treatment of progressive renal failure, including diabetic nephropathy
Richard Solomon, MD, FASN, FACP is the Patrick Professor of Medicine at the University of Vermont College of Medicine, and the Director of the Division of Nephrology and Hypertension at Fletcher Allen Health Care, in Burlington, Vermont. He received his MD degree from Yale Medical School, trained in Internal Medicine at the University of California, San Francisco, and Nephrology at Harvard Medical School. He is interested in acute kidney injury and in particular, prevention of contract induced nephropathy (CIN). He has been the principle investigator for a number of important trials in CIN prevention. he is a frequent reviewer for journals in Nephrology, Cardiology, and Radiology on the subject of acute kidney injury. He is a member of a number of Data Safety and monitoring Boards for national trials. He is a member of the NIH consortium for biomarkers of kidney injury. In addition to interests in acute kidney injury, he has been involved in studies of comparative physiology for the last 25 years at the Mt. Desert Island Marine Biology Laboratory, and an instructor in courses for medical residents who come to the laboratory.
University of Vermont, Patrick Professor of Medicine Medicine
Fletcher Allen Health Care Director, Division of Nephrology and Hypertension Medicine/Nephrology
1977, 1978 House Staff Teaching Award, Roger Williams General Hospital
Solomon R, Mehran R, Barrett B and the Investigators of the CARE trial. Contrast-Induced Nephropathy and Long-Term AEs: Cause and Effect? CJASN 2009, 4: 1162-1169.
Brown JR, Solomon RJ. Contrast-induced nephropathy morbidity and mortality following percutaneous coronary intervention. Am J Cardiol 2009, 104: 1763.Li J, Solomon R. Creatinine increases following intravenous contrast: incidence and impact. Invest Radiol. 2010 Aug;45(8):471-6.
Solomon, R. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J 2010, 159: e7.Solomon, R. and Dauerman, H. Contrast-induced acute kidney injury: Clinician Update, Circulation. 2010 Dec 7;122(23):2451-5.